- Investing Ideas
- French Pharmaceuticals & Biotech Buy the Dip
French Pharmaceuticals & Biotech Buy the Dip
Results
2
1 new
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
2 companies
DBV Technologies
Market Cap: €769.4m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
New
DBV
€2.60
7D
-8.8%
1Y
52.2%
Cellectis
Market Cap: €167.7m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
ALCLS
€2.31
7D
-10.8%
1Y
47.3%